SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Sanofi 
Flag of France emoji
  SEC # 1121404


        
5  Related Registrants:   

    Click to view...      Registrant      About      Filings      Files      Relationships      Names    
  Topics  
    Web       

159  Topics
Topic emoji
 within the 

Show:   Most-Recent Document   All Documents   And:   Exhibits  

 As Of  Filing  Doc.  Page    Title Docs.
  In ascending order
2/23/2420-F1A. Consolidated Financial Statements and Other Financial Information
1A. Directors and Senior Management
1A. History and Development of the Company
1A. Major Shareholders
1A. Offer and Listing Details
1A. Selected Financial Data
1A. Share Capital
1A/ Basis of preparation
4/4/24New Filing!  F-3ASR1About This Prospectus
2/23/2420-F1Additional Information
1Assets
1Audit Committee Financial Expert
1B. Business Overview
1B. Capitalization and Indebtedness
1B. Compensation
1B. Liquidity and Capital Resources
1B. Plan of Distribution
1B. Related Party Transactions
1B. Significant Changes
1B/ Summary of significant accounting policies
1C. Board Practices
1C. Interests of Experts and Counsel
1C. Markets
1C. Material Contracts
1C. Organizational Structure
1C. Reasons for Offer and Use of Proceeds
1C. Research and development, patents and licenses, etc
1C/ Principal alliances
4/4/24New Filing!  F-3ASR1Cautionary Statement Regarding Forward-Looking Statements
2/23/2420-F1Change in Registrant's Certifying Accountant
1Cies
4/4/24New Filing!  F-3ASR1Clearance and Settlement
2/23/2420-F1Code of Ethics
1Consolidated Balance Sheets -- Assets
1Consolidated Balance Sheets -- Equity and Liabilities
1Consolidated Income Statements
1Consolidated Statements of Cash Flows
1Consolidated Statements of Changes in Equity
1Consolidated Statements of Comprehensive Income
1Controls and Procedures
1Corporate Governance
1Cybersecurity
1D. Employees
1D. Exchange Controls
1D. Property, Plant and Equipment
1D. Risk Factors
1D. Selling Shareholders
1D. Trend information
1D/ Presentation of the financial statements
1Defaults, Dividend Arrearages and Delinquencies
4/4/24New Filing!  F-3ASR1Description of Debt Securities We May Offer
2/23/2420-F1Description of Securities Other Than Equity Securities
1Directors, Senior Management and Employees
1Disclosures Regarding Foreign Jurisdictions That Prevent Inspections
1E. Critical accounting estimates
1E. Dilution
1E. R&D Appendices
1E. Share Ownership
1E. Taxation
1E/ Principal accountants' fees and services
4/4/24New Filing!  F-3ASR1Enforceability of Certain Civil Liabilities
2/23/2420-F1Equity and Liabilities
1Exemptions From the Listing Standards for Audit Committees
6/28/2311-K1Exhibit
2/23/2420-F1Exhibits
4/4/24New Filing!  F-3ASR1Experts
2/23/2420-F1F. Disclosure of action to recover erroneously awarded compensation
1F. Dividends and Paying Agents
1F. Expenses of the Issue
1F/ List of principal companies included in the consolidation during 20
1Financial Information
1Financial Statements
1G. Statement by Experts
1G/ Events subsequent to December 31, 20
1H. Documents on Display
1I. Subsidiary Information
1Identity of Directors, Senior Management and Advisers
4/4/24New Filing!  F-3ASR1Incorporation by Reference
2/23/2420-F1Information on the Company
1Insider
1Introduction
1J. Annual Report to Security Holders
1Key Information
4/4/24New Filing!  F-3ASR1Legal Ownership
2/23/2420-F1Major Shareholders and Related Party Transactions
1Material Modifications to the Rights of Security Holders
1Memorandum and Articles of Association
1Mine Safety Disclosure
1Notes to the Consolidated Financial Statements
6/28/2311-K1Notes to the Financial Statements
2/23/2420-F1Offer and Listing, The
1Offer Statistics and Expected Timetable
1Operating and Financial Review and Prospects
1Operating results
1Part I
1Part Ii
1Part Iii
4/4/24New Filing!  F-3ASR1Plan of Distribution
4/4/24New Filing!  S-81Power of Attorney (included on the signature page)
4/4/24New Filing!  F-3ASR1Powers of Attorney of Sanofi (included in signature page of this registration statement)
2/23/2420-F1Principal Accountants' Fees and Services
4/4/24New Filing!  F-3ASR1Prospectus Summary
2/23/2420-F1Purchases of Equity Securities by the Issuer and Affiliated Purchasers
1Quantitative and Qualitative Disclosures About Market Risk
6/28/2311-K1Report of Independent Registered Public Accounting Firm
4/4/24New Filing!  F-3ASR1Risk Factors
6/28/2311-K1Schedule H, Line 4a -- Schedule of Delinquent Participant Contributions
1Schedule H, Line 4i -- Schedule of Assets (Held at End of Year)
1Schedule of Assets (Held at End of Year)
1Schedule of Delinquent Participant Contributions
1Signatures
1Statements of Changes in Net Assets Available for Benefits
1Statements of Net Assets Available for Benefits
1Supplemental Schedules
4/4/24New Filing!  F-3ASR1Table of Contents
1Taxation of Debt Securities
2/23/2420-F1The Offer and Listing
1Trading Poli
1Unresolved Staff Comments
4/4/24New Filing!  F-3ASR1Use of Proceeds
1Validity of Securities
1Where You Can Find More Information
2/23/2420-F1101
1110
1134
1141
1142
1145
1146
1147
1148
1150
1151
1152
1156
1160
1161
1165
1167
1168
1169
1171
1173
6/28/2311-K12-3
16-17

Top

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., Apr. 28, 1:42:11.2pm ET